Morten Grunnet, PhD, DrSc, is co-founder, board member and CSO at Acesion Pharma. Morten Grunnet brings +15 years of drug discovery experience from biotech at director level. He also has experience from big pharma in combination with a solid academic background as full professor and +100 publications. He has lead cross-disciplinary teams for a number of pre-clinical drug discovery projects within CNS and the cardiovascular field. Some of these projects have been strategic collaborations between biotech and big pharma companies. His special interest is on ion channels research in excitable tissues.
Excitable tissues